Intellipharmaceutics International Inc. Quarterly Assets, Current in USD from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: CAD and USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Intellipharmaceutics International Inc. quarterly Assets, Current history and growth rate from Q4 2010 to Q3 2023.
  • Intellipharmaceutics International Inc. Assets, Current for the quarter ending August 31, 2023 was $862K, a 55.3% increase year-over-year.
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $862K +$307K +55.3% Aug 31, 2023 6-K 2023-10-16
Q2 2023 $953K +$45.2K +4.97% May 31, 2023 6-K 2023-09-26
Q1 2023 $735K -$88.8K -10.8% Feb 28, 2023 6-K 2023-09-26
Q4 2022 $493K -$610K -55.3% Nov 30, 2022 20-F/A 2024-02-06
Q3 2022 $555K -$1.29M -69.9% Aug 31, 2022 6-K 2022-10-14
Q2 2022 $908K -$2.36M -72.2% May 31, 2022 6-K 2022-07-21
Q1 2022 $824K -$51.4K -5.87% Feb 28, 2022 6-K 2022-04-14
Q4 2021 $1.1M -$377K -25.5% Nov 30, 2021 20-F/A 2024-02-06
Q3 2021 $1.84M -$465K -20.1% Aug 31, 2021 6-K 2021-10-15
Q2 2021 $3.27M +$1.74M +114% May 31, 2021 6-K 2021-07-15
Q1 2021 $876K -$590K -40.2% Feb 28, 2021 6-K 2021-04-14
Q4 2020 $1.48M -$44.3K -2.91% Nov 30, 2020 20-F/A 2022-05-09
Q3 2020 $2.31M +$547K +31% Aug 31, 2020 6-K 2020-10-15
Q2 2020 $1.53M -$1.52M -49.9% May 31, 2020 6-K 2020-07-15
Q1 2020 $1.47M -$3.45M -70.2% Feb 29, 2020 6-K 2020-05-29
Q4 2019 $1.52M -$7.19M -82.5% Nov 30, 2019 20-F 2021-03-31
Q3 2019 $1.76M -$147K -7.69% Aug 31, 2019 6-K 2019-10-11
Q2 2019 $3.05M -$126K -3.96% May 31, 2019 6-K 2019-07-10
Q1 2019 $4.92M Feb 28, 2019 6-K 2019-04-15
Q4 2018 $8.72M +$5.15M +145% Nov 30, 2018 20-F 2020-03-30
Q3 2018 $1.91M Aug 31, 2018 6-K 2018-10-15
Q2 2018 $3.18M May 31, 2018 6-K/A 2018-07-24
Q4 2017 $3.56M Nov 30, 2017 6-K 2018-10-15
Q4 2015 $2.92M -$3.06M -51.2% Nov 30, 2015 20-F 2016-03-21
Q4 2014 $5.98M +$3.26M +119% Nov 30, 2014 20-F 2016-03-21
Q1 2014 $9.23M Feb 28, 2014 6-K 2014-04-14
Q4 2013 $2.73M +$1.79M +191% Nov 30, 2013 20-F 2015-02-27
Q4 2012 $939K -$4.36M -82.3% Nov 30, 2012 20-F 2014-02-18
Q4 2011 $5.3M +$3.18M +150% Nov 30, 2011 20-F/A 2013-02-01
Q4 2010 $2.12M Nov 30, 2010 20-F 2012-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.